Close X
Saturday, November 16, 2024
ADVT 
National

Ex-Quebec construction union boss found guilty of fraud, forging documents

Darpan News Desk Canadian Press, 26 Sep, 2014 11:06 AM

    MONTREAL - An influential former Quebec union boss has been found guilty of fraud and forging documents stemming from inflated expense claims.

    Jocelyn Dupuis was accused of charging the Quebec Federation of Labour for tens of thousands of dollars in expenses by using fake or inflated bills.

    Quebec court judge Denis Lavergne found him guilty on Friday of all the charges he was facing.

    The charges related to claims made between December 2007 and November 2008, a period in which Dupuis filed 43 expense accounts totalling $225,000.

    During the trial, provincial police witnesses testified that 144 bills were suspect, representing more than $63,000.

    Of those, half were fake bills with no verifiable transaction record available, police said.

    The other half were allegedly inflated, with investigators having tracked down original receipts they said were far less than what was billed for.

    The majority of the expenses were for lavish restaurant meals and expensive bottles of wine.

    Dupuis had suggested the inflated expenses were for the benefit of the workers he represented.

    Some former colleagues testified they approved of his practices because Dupuis often paid union expenses out of pocket.

    His lawyer argued there was no fraud and no malice and that the amounts he received ultimately made their way back to the membership.

    Dupuis was a key leader in the labour federation's construction wing, serving as director-general between 1997 and 2008.

    MORE National ARTICLES

    Tekmira in talks about using experimental Ebola drug in infected patients

    Tekmira in talks about using experimental Ebola drug in infected patients
    VANCOUVER - Tekmira Pharmaceuticals Corp. (TSX:TKM) is in discussions about making its experimental Ebola drug available to infected patients, but says there is no guarantee the treatment can be used to help quell the outbreak in West Africa.

    Tekmira in talks about using experimental Ebola drug in infected patients

    Vancouver police officer used too much force during traffic stop: watchdog

    Vancouver police officer used too much force during traffic stop: watchdog
    A Vancouver police officer used excessive and unnecessary force when he punched a driver three times during a traffic stop in 2012, said a ruling by B.C.'s police watchdog.

    Vancouver police officer used too much force during traffic stop: watchdog

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto
    A Calgary company is looking to boost the profile of the world's newest, and most controversial, currency with the launch of six more teller machines in Toronto that deal in the virtual currency Bitcoin.

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    White House talking to Canada, others about aiding Iraqi refugees

    White House talking to Canada, others about aiding Iraqi refugees
    The United States is considering a multinational mission to whisk displaced people to safety in Iraq and it appears there may be a supporting role for Canada.

    White House talking to Canada, others about aiding Iraqi refugees

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful
    A special prosecutor has approved polygamy charges against the two leaders of an isolated religious sect in southeastern British Columbia.

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    Ebola drug developer Tekmira's net loss widens during second quarter

    Ebola drug developer Tekmira's net loss widens during second quarter
    Tekmira Pharmaceuticals Corp. (TSX:TKM) says it's in talks with governments and non-governmental organizations in various countries about the potential use of its experimental Ebola drug in infected patients.

    Ebola drug developer Tekmira's net loss widens during second quarter